Drug Metabolism Discussion Group

About / Overview

Welcome to the North Jersey ACS Drug Metabolism Discussion Group. We are dedicated to fostering a continued discussion on the scientific advances in drug metabolism among the industrial and academic community. We sponsor multiple meetings each year at which world renowned scientists give presentations. The format of these meetings range from dinner presentations and mini-symposia, to our biannual full day symposia.

Board Members

Arian Emami Riedmaier

Arian Emami Riedmaier

Chair (2021-Present)

Imad Hanna

Imad Hanna

Past Chair (2019-2023)

Keroles Nakhla

Keroles Nakhla

Treasurer

Matthew Hoffmann

Matthew Hoffmann

Past Treasurer

Vijay More

Vijay More

Secretary

Li Yu

Li Yu

Vendor Liaison

Bonnie Brennan

Bonnie Brennan

Member

Anima Ghosal

Anima Ghosal

Member

Anima Ghosal

Anima Ghosal

Member

Niyu Zheng

Niyu Zheng

Member

Jianwei Zhao

Jianwei Zhao

Member

Nina Tong

Nina Tong

Member

Brittany Tran

Brittany Tran

Member

Jingjing Guo

Jingjing Guo

Member

Holly Maw

Holly Maw

Member

Libo Xu

Libo Xu

Member

Bo Wen

Bo Wen

Member

Manthena Varma

Manthena Varma

Member

Lauren Aleksunes

Lauren Aleksunes

Member

2024 Spring Symposium and Vendor Exhibition (Drug Metabolism Discussion Group )

April 11, 2024 | 8am - 4pm

Discovery, Development, and Regulatory Strategy for Biologics and ADCs in Oncology and Immunology

Program
8:00 a.m. Registration / Continental Breakfast / Vendor Exhibit
8:45 a.m. Introductory Remarks

Arian Emami Riedmaier, PhD; Chair, NJ DMDG

9:00 a.m. The Evolution of First-in-Human Dose Selection for Biologics in Oncology and Beyond

Haiqing Wang, PhD; Senior Director, DMPK, Alnylam

9:45 a.m. Mutants, Loners and Bad Influences (Systems Model of KRAS Pathway Describing Mechanism of Response in G13D CRC)

Edward Stites, MD, PhD; Associate Professor of Laboratory Medicine and Pathology, Yale School of Medicine

10:30 a.m. Vendor Exhibit & Coffee Break
11:15 a.m. Mitochondrial Bioenergetic Health Index as a Biomarker for Kidney Injury

Kiran Deshpande; PhD Candidate, Ernest Mario School of Pharmacy Rutgers, New Brunswick, NJ

11:45 p.m. Vendor Exhibit & Lunch
12:45 p.m. Immunogenicity Risk Assessments and Bioanalytical Strategy for IND Enabling Studies for Complex Biologics

Sanjay Dholakiya, PhD; Principal Scientist, BMS

1:30 p.m. Developing Effective Drug Development Strategies for Biologics

Samuel Chuang, PhD; Senior Director, Scientific Advisory Services, Charles River

2:15 p.m. Vendor Exhibit & Coffee Break
2:30 p.m. ADCs as Therapeutic Options: History, Resurgence and DXd Based ADCs from DSI

Tushar Garimella, PhD; Executive Director, Clinical Pharmacology, Daiichi-Sankyo

3:15 p.m. Medicilon Strategy & Experience for Dual Filing of ADC IND to US FDA & China NMPA

Chunlin Chen, PhD; CEO and Founder, Medicilon USA Corp.

4:00 p.m. Program close

Registration information

  • Early-bird fee (prior to March 1, 2024) is $125. Pre-registration after the early-bird date is $150. We are also offering one free attendee for every five that are pre-registered from the same companyRegistration fee at the door is $200
  • Registration fee for students and postdocs is $10 and $50 for faculty
  • Registration is free for unemployed attendees
  • If feasible, please plan to pre-register as a group, as coordinated by a member of the NJACS DMDG steering committee from your organization (see list on the following page)
  • If you have no DMDG member at your company, please contact Arian Emami Riedmaier (arian.emamiriedmaier@certara.com) or Keroles Nakhla (keroles.nakhla@novartis.com) for registration
  • Payments by personal or company checks or credit cards or registration on this site

Checks should be made payable to: NJ Drug Metabolism Discussion Group. Or please register and pay on this site.

Exhibitors

Please contact Li Yu (liyu.pharmaconsulting@gmail.com) for information concerning exhibits

Save the Date

Meeting Archives

Go to Top